Overview

Combination Therapy of Anthracyclines for Children With Nephroblastoma

Status:
Not yet recruiting
Trial end date:
2045-06-30
Target enrollment:
Participant gender:
Summary
This study aims to estimate the efficacy and side effects of study drugs in children with nephroblastoma who are treated with combination therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Shengjing Hospital
Treatments:
Cyclophosphamide
Dactinomycin
Doxorubicin
Epirubicin
Liposomal doxorubicin
Oxytetracycline
Pirarubicin
Vincristine